
News|Slideshows|October 6, 2022
4 New Drugs Approved for Primary Care: Q3 2022
Author(s)Sydney Jennings
Advertisement
The third quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US Food and Drug Administration for conditions that are often seen in primary care. In the slides below, find details on a novel rapid-acting treatment for major depressive disorder that was the first of its kind to receive approval from FDA, a novel treatment for plaque psoraisis, and more.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Centanafadine XR Meets Phase 3b ADHD Endpoint in Adults With Comorbid Anxiety
2
Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone
3
Tirzepatide and Emerging OSA Pharmacotherapy Expand the Treatment Toolkit, With Ashesha Mechineni, MD
4
OSA Treatment Beyond CPAP: Tirzepatide, Phenotyping, and What's Next, With Ashesha Mechineni, MD
5






















































































































































































































